Response to 'HIVAN is increasingly less common in HIV-positive Black Africans living in Europe' [4]

Kidney International

Volumn 70, Issue 9, 2006, Pages 1662-1663

  Gerntholtz, T E ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AFRICA SOUTH OF THE SAHARA; CD4 LYMPHOCYTE COUNT; EUROPE; EXPERIENCE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS ASSOCIATED NEPHROPATHY; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNE COMPLEX NEPHRITIS; KIDNEY BIOPSY; KIDNEY DISEASE; LETTER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TISSUE SECTION; WORLD HEALTH ORGANIZATION;

EID: 33750211475     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001881     Document Type: Letter

References (2)

1. Cove Smith A, Sheaff MT, Ashman N. HIVAN is increasingly less common in HIV-positive Black Africans living in Europe. Kidney Int (in press).
2. Gerntholtz TE, Goetsch SJ, Katz I. HIV-related nephropathy: a South African perspective. Kidney Int 2006; 69: 1885-1891.